Acute tolerance to spinally administered morphine compares mechanistically with chronically induced morphine tolerance

Journal of Pharmacology and Experimental Therapeutics

Volumn 282, Issue 3, 1997, Pages 1408-1417

  Fairbanks, Carolyn A ^a   Wilcox, George L ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b 3 249 Millard Hall ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 NITROINDAZOLE; AGMATINE; DECAHYDRO 6 PHOSPHONOMETHYL 3 ISOQUINOLINECARBOXYLIC ACID; DIZOCILPINE; HOT WATER; IMIDAZOLINE DERIVATIVE; MORPHINE SULFATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME INHIBITION; INTRATHECAL DRUG ADMINISTRATION; MALE; MORPHINE TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TAIL FLICK TEST;

AGMATINE; ANALGESICS, OPIOID; ANIMALS; DRUG TOLERANCE; INDAZOLES; INJECTIONS, SPINAL; MALE; MICE; MICE, INBRED ICR; MORPHINE; NITRIC OXIDE SYNTHASE; RECEPTORS, N-METHYL-D-ASPARTATE; SPINAL CORD;

EID: 0030967429     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (86)

1. ABELIOVICH, A., PAYLOR, R., CHEN, C., KIM, J. J., WEHNER, J. M. AND TONEGAWA, S.: PKC Gamma mutant mice exhibit mild deficits in spatial and contextual learning. Cell 75: 1263-1271, 1993.
2. AUGUET, M., VIOSSAT, I., MARIN, J. G. AND CHABRIER, P. E.: Selective inhibition of inducible nitric oxide synthase by agmatine. Jpn. J. Pharmacol. 69: 285-287, 1995.
3. BEHAR, M., MAGORA, F., OLSHWANG, D. AND DAVIDSON, J. T.: Epidural morphine in treatment of pain. Lancet. 1: 527-529, 1979.
4. BEN-ELIYAHU, S., MAREK, P., VACCARINO, A. L., MOGIL, J. S., STERNBERG, W. F. AND LIEBESKIND, J. C.: The NMDA receptor antagonist MK-801 prevents long-lasting non-associative morphine tolerance in the rat. Brain Res. 575: 304-308, 1992.
5. BHARGAVA, H. N.: Attenuation of tolerance to, and physical dependence on, morphine in the rat by inhibition of nitric oxide synthase. Gen. Pharmacol. 26: 1049-1053, 1995.
6. 2 and protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice. J. Pharmacol. Exp. Ther. 277: 484-490, 1996a.
7. BILSKY, E. J., BERNSTEIN, R. N., HRUBY, V. J., ROTHMAN, R. B., LAI, J. AND PORRECA, F.: Characterization of antinociception to opioid receptor selective agonists after antisense oligodeoxynucleotide-mediated "knock-down" of opioid receptors in vivo. J. Pharmacol. Exp. Ther. 277: 491-501, 1996b.
8. BILSKY, E. J., INTURRISI, C. E., SADEE, W., HRUBY, V. J. AND PORRECA, F.: Competitive and noncompetitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective mu or delta opioid agonists in mice Pain 68: 229-237, 1996c.
9. BLASIG, J., HERZ, A., REINHOLD, K. AND ZIEGLGANSBERGER, S.: Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats. Psychopharmacologia. 33: 19-38, 1973.
10. 2+ block of NMDA-receptor channels as a mechanism of modulation. Nature 356: 521-523, 1992.
11. CLARK, F. M. AND PROUDFIT, H. K.: Anatomical evidence for genetic differences in the innervation of the rat spinal cord by noradrenergic locus coeruleus neurons. Brain Res. 591: 44-53, 1992.
12. COOMBS, D. W., FRATKIN, J. D., MEIER, F. A., NIERENBERG, D. W. AND SAUNDERS, R. L.: Neuropathologic lesions and CSF morphine concentrations during chronic continous intraspinal morphine infusion. A clinical and post-mortem study. Pain 22: 337-351, 1985.
13. COUSINS, M. J., MATHER, L. E., GLYNN, C. J., WILSON, P. R. AND GRAHAM, J. R.: Selective spinal analgesia. Lancet 1: 1141-1142, 1979.
14. COX, B. M., GINSBURG, M. AND OSMAN, O. H.: Acute tolerance to narcotic analgesic drugs in rats. Br. J. Pharm. 2: 245-256, 1968.
15. DELANDER, G. E., PORTOGHESE, P. S. AND TAKEMORI, A. E.: Role of spinal mu opioid receptors in the development of morphine tolerance and dependence. J. Pharmacol. Exp. Ther. 231: 91-96, 1984.
16. DELANDER, G. E. AND TAKEMORI, A. E.: Spinal antagonism of tolerance and dependence induced by systemically administered morphine. Eur. J. Pharmacol. 94: 35-42, 1983.
17. ELLIOTT, K., HYNANSKY, A. AND INTURRISI, C. E.: Dextromethorphan attenuates and reverses analgesic tolerance to morphine. Pain 59: 361-368, 1994a.
18. ELLIOTT, K., MINAMI, N., KOLESNIKOV, Y. A., PASTERNAK, G. W. AND INTURRISI, C. E.: The NMDA receptor antagonists, LY274614 and MK-801, and nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance Ut the mu-opioid morphine but not kappa opioids. Pain 56: 69-75, 1994b.
19. FAIRBANKS, C. A. AND WILCOX, G. L.: Imidazoline receptor (I1) selective agonists: antinociceptive profile, modulation of morphine antinociception, and attenuation of the development of morphine tolerance. American Pain Society: 15th Annual Scientific Meeting Abstr. p. A-123. 1996.
20. FARACI, F. M. AND BRIAN, J. E., JR.: 7-Nitroindazole inhibits brain nitric oxide synthase and cerebral vasodilatation in response to N-methyl-D-aspartate. Stroke 26: 2172-2175, 1995.
21. FIORILLO, C. D. AND WILLIAMS, J. T.: Opioid desensitization: interactions with G-protein-coupled receptors in the locus coeruieus. J. Neurosci. 16: 1479-1485, 1996.
22. GALEA, E., REGUNATHAN, S., ELIOPOULOS, V., FEINSTEIN, D. L. AND REIS, D. J.: Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine. Biochem J. 316: 247-249, 1996.
23. HAXHIU, M. A., DRESHAJ, I., SCHAFER, S. G. AND ERNSBERGER, P.: Selective antihypertensive action of moxonidine is mediated mainly by I1-imidazoline receptors in the rostral ventrolateral medulla. J. Cardiovasc. Pharmacol. 24: S1-8, 1994.
24. HUANG, Z., HUANG, P. L., PANAHIAN, N., DALKARA, T., FISHMAN, M. C. AND MOSKOWITZ, M. A.: Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 265: 1883-1885, 1994.
25. HUIDOBRO-TORO, J. P. AND WAY, E. L.: Single-dose tolerance to antinociception, and physical dependence on beta-endorphin in mice. Eur. J. Pharmacol. 52: 179-189, 1978.
26. HYLDEN, J. L. K. AND WILCOX, G. L.: Intrathecal morphine in mice: a new technique. Eur. J. Pharmacol. 67: 313-316, 1980.
27. JANSSEN, P. A., NIEMEGEERS, C. J. E. AND DONY, J. G. H.: The inhibitory effect of fentanyl and other morphine-like analgesics on the warm water induced withdrawal reflex in rats. Arzneim. Forsch. 13: 502-507, 1963.
28. KHANNA, J. M., MIHIC, S. J., WEINER, J. SHAH, G., WU, P. H. AND KALANT, H.: Differential inhibition by NMDA antagonists of rapid tolerance to, and cross-tolerance between, ethanol and chloridazepoxide. Brain Res. 574: 251-6, 1992.
29. KHANNA, J. M., MORATO, G. S., CHAU, A., SHAH, G. AND KALANT, H.: Effect of NMDA antagonists on rapid and chronic tolerance to ethanol: importance of intoxicated practice. Pharmacol. Biochem. Behav. 48: 755-63, 1994.
30. KHANNA, J. M., SHAH, G., WEINER, J., WU, P. H. AND KALANT, H.; Effect of NMDA receptor antagonists on rapid tolerance to ethanol. Eur. J. Pharmacol. 230: 23-31, 1993.
31. KISSIN, I., BROWN, P. T. AND BRADLEY, E., JR.: Magnitude of acute tolerance to opioids is not related to their potency. Anesthesiology 75: 813-816, 1991a.
32. KISSIN, I., BROWN, P. T., ROBINSON, C. A. AND BRADLEY, E., JR.: Acute tolerance in morphine analgesia: continuous infusion and single injection in rats. Anesthesiology 74: 166-171, 1991b.
33. KITTO, K. F., HALEY, J. E. AND WILCOX, G. L.: Involvement of nitric oxide in spinally mediated hyperalgesia in the mouse. Neurosci. Lett. 148:1-5, 1992.
34. KOLESNIKOV, Y., JAIN, S. AND PASTERNAK, G. W.: Modulation of opioid analgesia by agmatine. Eur. J. Pharmacol. 296: 17-22, 1996.
35. KOLESNIKOV, Y. A., PICK, C. G., CISZEWSKA, G. AND PASTERNAK, G. W.: Blockade of tolerance to morphine but not kappa opioids by a nitric oxide synthesis inhibitor. Proc. Natl. Acad. Sci. U.S.A. 90: 5162-5166, 1993.
36. KOLESNIKOV, Y. A., PICK, C. G. AND PASTERNAK, G. W.: N-G-Nitro-L-arginine prevents morphine tolerance. Eur. J. Pharmacol. 221: 399-400, 1992.
37. LAI, J., RIEDL, M., STONE, L. S., ARVIDSSON, U., BILSKY, E. J., WILCOX, G. L., ELDE, R. AND PORRECA, F.: Immunofluorescence analysis of antisense oligodeoxynucleotide-mediated "knock-down" of the mouse δ opioid receptor in vitro and in vivo. Neurosci. Lett. 213: 205-208, 1996.
38. LE, A. D., MANA, M., QUAN, B. AND KALANT, H.: Differential development of acute tolerance to the motor impairment and anticonvulsant effects of ethanol. Psychopharmacology 109: 107-111, 1992.
39. LI, G., REGUNATHAN, S., BARROW, C. J., ESHRACHI, J., COOPER, R. AND REIS, D. J.: Agmatine: an endogenous clonidine-displacing substance in the brain [see comments]. Science 263: 966-969, 1994.
40. LINK, R. E., DESAI, K., HEIN, L., STEVENS, M. E., CHRUSCINSKI, A., BERNSTEIN, D., BARSH, G. S. AND KOBILKA, B. K.: Cardiovascular regulation in mice alpha(2)-adrenergic receptor subtypes B and C. Science 273: 803-806, 1996.
41. 2a-adrenergic receptor subtype. Science 273: 801-803, 1996.
42. MAJEED, N. H., PRZEWLOCKA, B., MACHELSKA, H. AND PRZEWLOCKI, R.: Inhibition of nitric oxide synthase attenuates the development of morphine tolerance and dependence in mice. Neuropharmacology 33: 189-192, 1994.
43. MALDONADO, R., BLENDY, J. A., TZAVARA, E., GASS, P., ROQUES, B. P., HANOUNE, J. AND SCHUTZ, G.: Reduction of morphine abstinence in mice with a mutation in the gene encoding CREB. Science 273: 657-659, 1996.
44. MAREK. P., BEN-ELIYAHU, S., GOLD, M. AND LIEBESKIND, J. C.: Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the developing of morphine tolerance in the rat. Brain Res. 547: 77-81, 1991.
45. MEYER, D. R. AND SPARBER, S. B.: A comparison of withdrawal in rats with different types of morphine pellets. Pharm. Biochem. Behav. 5: 603-607, 1976.
46. MILLAN, M. J., CZLONKOWSKI, A., LIPKOWSKI, A. AND HERZ, A.: Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action. J. Pharmacol. Exp. Ther. 251: 342-350, 1989.
47. MOORE, P. K., WALLACE, P., GAFFEN, Z., HART, S. L. AND BABBEDGE, R. C.: Characterization of the novel nitric oxide synthase inhibitor 7-nitro indazole and related indazoles: antinociceptive and cardiovascular effects. Br. J. Pharmacol. 110: 219-224, 1993.
48. MUCHA, R. F. AND KALANT, H.: Log dose/response curve flattening in rats after daily injection of opiates. Psychopharmacology 71: 51-61, 1980.
49. NARITA, M., NARITA, M., MIZOGUCHI, H. AND TSENG, L. F.: Inhibition kinase C, but not of protein kinase A, blocks the development of antinociceptive tolerance to an intrathecally administered mu-opioid receptor agonist in the mouse. Eur. J. Pharmacol. 280: R1-3, 1995.
50. NIELSEN, J. A. AND SPARBER, S. B.: Indomethacin facilitates acute tolerance to and dependence upon morphine as measured by changes in fixed-ratio behavior and rectal temperature in rats. Pharmacol. Biochem. Behav. 22: 921-931, 1985.
51. ONOFRIO, B. M., YAKSH, T. L. AND ARNOLD, P. G.: Continuous low-dose intrathecal morphine administration in the treatment of chronic pain of malignant origin. Mayo Clin Proc. 56: 516-520, 1981.
52. RADY, J. J., ROERIG, S. C. AND FUJIMOTO, J. M.: Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception. J. Pharmacol. Exp. Ther. 256: 448-457, 1991.
53. RAFI-TARI, S., KALANT, H., LIU, J. F., SILVER, I. AND WU, P. H.: Dizocilpine prevents the development of tolerance to ethanol-induced error on a circular maze teat. Psychopharmacology 125: 23-32, 1996.
54. RASMUSSEN, K., FULLER, R. W., STOCKTON, M. E., PERRY, K. W., SWINFORD, R. M. AND ORNSTEIN, P. L.: NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal. Eur. J. Pharmacol. 197: 9-16, 1991.
55. ROSENFELD, G. C. AND BURKS, T. F.: Single-dose tolerance to morphine hypothermia in the rat: Differentiation of acute from long-term tolerance. J. Pharmacol. Exp. Ther. 202: 654-655, 1977.
56. ROVATI, L. C., SACERDOTE, P., BIANCHI, M. AND PANERAI, A. E.: Chronic intrathecal cannulation affects hypothalamic beta-endorphin and met-enkephalin concentrations. J. Pharmacol. Methods. 19: 85-88, 1988.
57. SABBE, M., MJANGER, E., SOSNOWSKI, M. AND YAKSH, T. L.: Study on tolerance development after daily epidural injection of sufentanil in dogs. Anesthesiology 69: A392, 1988.
58. SAMUELSSON, H., MALMBERG, F., ERIKSSON, M. AND HEDNER, T.: Outcomes of epidural morphine treatment in cancer pain: nine years of clinical experience. J. Pain Symptom Manage. 10: 105-112, 1995.
59. SAMUELSSON, H., NORDBERG, G., HEDNER, T. AND LINDQUIST, J.: CSF and plasma morphine concentrations in cancer patients during chronic epidural morphine therapy and its relation to pain relief. Pain 30: 303-310, 1987.
60. SCHMIDT, C. F. AND LIVINGSTON, A. E.: The action of morphine on the mammalian circulation. J. Pharmacol. Exp. Ther. 47: 411-442, 1933a.
61. SCHMIDT, C. F. AND LIVINGSTON, A. E.: A note concerning the actions of pseudomorphine. J. Pharmacol. Exp. Ther. 47: 471-485, 1933b.
62. SCHMIDT, C. F. AND LIVINGSTON, A. E.: The relation of dosage to the development of tolerance to morphine in dogs. J. Pharmacol. Exp. Ther. 47: 443-470, 1933c.
63. SIEGEL, S.: State dependent learning and morphine tolerance. Behav. Neurosci. 102: 228-232, 1988.
64. SONG, Z. H. AND TAKEMORI, A. E.: Modulation of acute morphine tolerance by corticotropin-releasing factor and dynorphin A in the mouse spinal cord. Life Sci. 51: 107-111, 1992.
65. SPARBER, S. B., GELLERT, V. F. AND FOSSOM, L.: On the use of operant behavior to study the neuropsychopharmacology of opiates with special reference to morphine and its relationship to dopamine in the central nervous system. Adv. Biochem. Psychoph. 20: 453-491, 1979.
66. SPARBER, S. B., GELLERT, V. F., LICHTBLAU, L. EISENBERG, R.: The use of operant behavior methods to study aggression and effects of acute and chronic morphine administration in rats. In Factors Affecting the Action of Narcotics, ed. bv M. L. Adler, L. Manara and R. Samanin, pp. 63-91, Raven Press, New York. 1978.
67. STANDIFER, K. M., CHIEN, C. C., WAHLESTEDT, C., BROWN, G. P. AND PASTERNAK, G. W.: Selective loss of delta opioid analgesia and binding by antisense oligodeoxynucleotides to a delta opioid receptor. Neuron. 12: 805-810, 1994.
68. STEVENS, C. W.: Perspectives on opioid tolerance from basic research: behavioral studies after spinal administration in rodents. Cancer Sur. 21: 25-47, 1994.
69. STEVENS, C. W.: Relative analgesic potency of mu, delta, and kappa opioids after spinal administration in amphibians. J. Pharmacol. Exp. Ther. 276: 440-448, 1996.
70. TALLARIDA, R. J. AND MURRAY, R. B.: Manual of Pharmacologie Calculations with Computer Programs. Springer-Verlag, New York, 1987.
71. TISEO, P. J., CHENG, J., PASTERNAK, G. W. AND INTURRISI, C. E.: Modulation of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist LY274614: assessment of opioid receptor changes. J. Pharmacol. Exp. Ther. 268: 195-201, 1994.
72. TISEO, P. J. AND INTURISSI, C. E.: Attenuation and reversal of morphine tolerance by the competitive NMDA receptor antagonist, LY274614. J. Pharmacol. Exp. Ther. 264: 1090-1096, 1993.
73. TRUJILLO, K. A. AND AKIL, H.: Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251: 85-87, 1991.
74. VAUGHT, J. L., KITANO, T. AND TAKEMORI, A. E.: Interactions of leucine enkephalin and narcotics with opioid receptors. Mol. Pharmacol. 19: 236-241, 1981.
75. VAUPEL, D. B., KIMES, A. S. AND LONDON, E. D.: Comparison of 7-nitro indazole with other nitric oxide synthase inhibitors as attenuators of opioid withdrawal. Psychopharmacology 118: 361-368, 1995a.
76. VAUPEL, D. B., KIMES, A. S. AND LONDON, E. D.: Nitric oxide synthase inhibitors: Preclinical studies of potential use for treatment of opioid withdrawal. Neuropsychopharmacology 13: 315-322, 1995b.
77. WANG, H. AND SAGEN, J.: Absence of appreciable tolerance and morphine cross-tolerance in rats with adrenal medullary transplants in the spinal cord. Neuropharmacology 33: 681-692, 1994.
78. WANG, J. K., NAUSS, L. A. AND THOMAS, J. E.: Pain relief by intrathecally applied morphine in man. Anesthesiology 50: 149-151, 1979.
79. WIESENFELD, Z. AND GUSTAFSSON, L. L.: Continuous intrathecal administration of morphine via an osmotic minipump in the rat. Brain Res. 247: 195-197, 1982.
80. WU, H. H., WILCOX, G. L. AND MCLOON, S. C.: Implantation of AtT-20 or genetically modified AtT-20/hENK cells in mouse spinal cord induced antinociception and opioid tolerance. J. Neurosci. 14: 4806-4814, 1994.
81. WU, P. H., MIHIC, S. J., LIU, J. F., LE, A. D. AND KALANT, H.: Blockade of chronic tolerance to ethanol by the NMDA antagonist, (+)-MK-801. Eur. J. Pharmacol. 231: 157-64, 1993.
82. YAKSH, T. L., HUANG, S. P. AND RUDY, T. A.: The direct and specific opiate-like effect of met(5)-enkephalin and analogues on the spinal cord. Neuroscience 2: 593-596, 1977.
83. YAKSH, T. L. AND RUDY, T. A.: Chronic catheterization of the spinal subarachnoid space. Physiol. Behav. 17: 1031-1036, 1976.
84. YANG, X. C., AND REIS, D. L.,: Agmatine blocks NMDA receptor channels in rat hippocampal neurons. Soc. Neurosci. Abstr. 22: 338, 1996
85. YANO, I. AND TAKEMOKI, A. E.: Inhibition by naloxone of tolerance and dependence in mice treated acutely and chronically with morphine. Res. Commun. Chem. Path. 16: 721-734, 1977.
86. YOUNG, C. W., ROBINSON, P. F. AND SACKTOR, B.: Inhibition of the synthesis of protein in intact animals by acetoxycycloheximide and a metabolic derangement concomitant with this blockade. Biochem. Physiol. 12: 855-865, 1963.